Background: This study assesses whether national initiatives undertaken to improve diversity in clinical trial enrollment have been successful within head and neck cancer (HNC) trials.
Methods: A retrospective analysis was conducted of HNC trials published on clinicaltrials.gov with start dates between 2000 and 2023.